Welcome to

Equity Bridge Consulting

Medical Affairs

Equity Bridge Consulting is the only Medical Affairs ​company that leverages the expertise of medical ​professionals and academic experts along with ​established community partnerships specific to bridging ​the diversity gap in clinical research.

Orange Blur Circle Illustration

About Us

Our Approach to Medical ​Affairs

Learn more about The EBC Way, our three-​tiered path towards FDORA compliance.

Mother and Baby in the Beach at Sunset

Our​ Mission and Vision

We’re out to change the world. Here’s how.

African-American nurse holding crystal globe in hands

Reaching People Across the ​Globe

Equity Bridge Consulting is best positioned to ​help our partners achieve their global strategic ​goals.

Our Leadership

Meet our Founder and President.

Man on Phone

Contact Us

Ready to get started or lean more? Let’s start​ a conversati​on.

About Us

Orange Blur Circle Illustration

Ou​r Vision

Our vision is to create a healthier world for everyone.

Our Mi​ssion

Equity Bridge Consulting provides scientific support to ​pharmaceutical, biotechnology, diagnostics, or other ​medical affairs providers to increase the inclusion of ​populations that have historically been un- or ​underrepresented in research and clinical trials. In doing ​so, we promise to always adhere to our core values of ​respect, transparency, honesty, research integrity, and ​inclusion. We do so in a manner that respects the ​historical context of such work and ultimately benefits ​our partners, these communities, and all other ​stakeholders involved.

Our Leadership

Adalynn E. Harris, PhD, MPH, MHA

Founder and President


Dr. Harris is a scientist, educator, and public health proponent who has been committed to health equity and ​community engagement for over 25 years. Throughout her fifteen year career in the medical affairs division of the ​pharmaceutical industry, where she specialized in oncology and rare disease clinical trials, Dr. Harris has co-​authored research articles and offered presentations to fellow professionals about emerging therapies, health ​disparities, and current scientific research. Dr. Harris is a proponent for representation of minority, ​underrepresented, and disenfranchised groups in clinical trials and public health policy and organizes discussions, ​collaborations, and dissemination of medical information to key stakeholders, including principal investigators, ​advisory boards, physicians, nurses, pharmacists, and peers in the pharmaceutical industry. Through Equity ​Bridge Consulting, Dr. Harris remains dedicated to opening opportunities for the advancement of medical ​knowledge and practices, specifically for minority communities within the US, persons in sub-Saharan Africa, and ​those from the African diaspora worldwide.


  • Ph.D. in Biomedical Sciences, Morehouse School of Medicine
  • Post - Doctoral Research: Winship Cancer Institute, Emory University
  • Post - Doctoral Research: Neuroscience Institute, Morehouse School of Medicine
  • Post-Doctoral Fellowship: Fellowship In Research and Science Teaching (FIRST) Emory University
  • Master of Public Health, UNC-Chapel Hill
  • Master of Health Administration, George Washington University
  • BS in Biology, North Carolina A&T State University
  • Career Experience: Medical Affairs Experience: 15+ years in the pharmaceutical industry - Clinical ​Trial/Scientific Support; Health Disparities; Strategy Design and Implementation; Advisory Board ​Facilitation
  • Academic positions: Adjunct Professor at NC A&T State University, Georgia Perimeter, and Guilford ​Technical Community Collège
Orange Blur Circle Illustration

The Problem

Racial and ethnic minorities are sorely unrepresented in clinical trials.

Paint Brush Stroke

85% of the World’s Population

Are people of people of Indigenous, African, Asian, or Latin American descent, yet they only ​make up less than 20% of clinical trial participants.

Less than 3%

Of cancer (2.8%) and cardiovascular (2.5%) clinical trial participants are African Americans, ​even though these Americans have the highest mortality rate related to these diseases.

5.6 Million People

Over 65 years of age have Alzheimer’s disease/other dementias and older African Americans ​are twice as likely to have it versus older whites.

Only 2.5%

Percent of clinical trials include participants in Africa yet Africa has 25% of the world’s ​disease burden.​

Our Solution

The Equity Bridge Consulting Approach leverages published data from evidenced based research to ​increase clinical trial diversity. Our Approach focuses on three areas to garnish impactful change.

Number 1

Increase industry ​bandwidth to provide ​efficient medical affairs ​expertise

Political candidate speaks to crowd during town hall meeting
Number 2

Medical Community and ​Patient Advocacy Education ​to overcome barriers to ​participation

Number 3

Healthcare Workforce ​Diversification to build an ​accessible pipeline of ​medical professionals

Reaching people across the globe

Orange Blur Circle Illustration
Orange Blur Circle Illustration

In today’s medical affairs' landscape, the ability to reach populations that are representative of the planet is ​paramount for success. From the United States to the Carribean to Sub-Saharan Africa and other parts of the ​world, Equity Bridge Consulting is best positioned to help our partners achieve their global strategic goals.

Talks and

Appearances


May 31, AME Zion Midwest Mega ​Conference, Indianapolis In

Dr. Harris Presents to Leading African American ​Faith Based Community.

February 1-15th, Urban League of Central ​Carolinas, the Urban League of North ​Carolina and South Carolina and High Point ​University

Dr. Harris speaks to community leaders, educators, ​and students about disparities in healthcare.

Africa Hepatopancreatobilary Cancer ​Consortium, Accra, Ghana , West Africa

Dr. Harris Presents on Clinical Trial Capabilities in ​West Africa.

Articles and ​News

Dr. Harris and Co-authors delineate cancer ​healthcare disparities in ethnic minorities

Dr. Harris and co-authors shed a spotlight on ​the lack of research conducted in Sub-Saharan ​Africa

Recently published guidelines from the FDA aim ​to expand eligibility criteria in clinical trials

Pharmaceutical industry

FDA mandates that trial populations are ​representative of those with the ​disease/condition

Dr. Bennett brings a welcomed approach to our ​marketing efforts. Learn more about Dr. Bennett.

Our Partners

Trusted by the leaders in pharmaceutical, biotechnology and diagnostics ​industries and other medical affairs providers


Equity Bridge Consulting, we move research forward

Orange Blur Circle Illustration
Professional group portrait
Orange Blur Circle Illustration

Equity Bridge Consulting

Medical Affairs

Inspiring Impactful Change in Health Equity

We move research forward.

Address location Outline icon

©Equity Bridge Consulting

© Equity Bridge LL​C

POBox 587​1

Greensboro North Carolina, 2743​5

email icon email  text message letter text
Phone Number Icon

EquityBridgeLLC@yahoo.com



336 - 343 - 2583

© 2023 Equity Bridge Consulting. All rights reserved